Pure Global

“Wistron Medical” IntelliBridge Enterprise (Non-Sterile) - Taiwan Registration 80d1a47468a9c3af4b6a94fee1164dfb

Access comprehensive regulatory information for “Wistron Medical” IntelliBridge Enterprise (Non-Sterile) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 80d1a47468a9c3af4b6a94fee1164dfb and manufactured by WISTRON MEDICAL TECHNOLOGY CORPORATION. The authorized representative in Taiwan is WISTRON MEDICAL TECHNOLOGY CORPORATION.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
80d1a47468a9c3af4b6a94fee1164dfb
Registration Details
Taiwan FDA Registration: 80d1a47468a9c3af4b6a94fee1164dfb
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

“Wistron Medical” IntelliBridge Enterprise (Non-Sterile)
TW: “緯創醫學” 醫療資料界接整合系統(未滅菌)
Risk Class 1
MD

Registration Details

80d1a47468a9c3af4b6a94fee1164dfb

Ministry of Health Medical Device Manufacturing No. 007405

Company Information

Taiwan, Province of China

Product Details

The main function of this software system is to convert the patient's physiological parameters (such as heartbeat, pulse, blood pressure, respiration rate, blood oxygen concentration, etc.) to the computer system through the physiological monitor, and use the connection authorization as the main information service, which can perform the communication, data correspondence, message transmission, and data transmission and exchange between the Wistron Medical software system and the hospital system, the following blank.

P Devices for radiology

P9999 Other

Produced in Taiwan, China

Dates and Status

Aug 28, 2018

Aug 28, 2023